163 related articles for article (PubMed ID: 19038767)
1. Neoadjuvant chemotherapy with high-dose methotrexate in osteosarcoma.
Mir O; Ropert S; Goldwasser F
Lancet Oncol; 2008 Dec; 9(12):1198. PubMed ID: 19038767
[No Abstract] [Full Text] [Related]
2. [Progress and stagnation in chemotherapy protocols for primary osteosarcoma].
Delépine N; Alkallaf S; Cornille H; Markowska B; Delépine G
Ann Med Interne (Paris); 2003 Feb; 154(1):12-24. PubMed ID: 12746655
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in the chemotherapy of metastatic osteogenic sarcoma. 1972.
Jaffe N
Clin Orthop Relat Res; 1991 Sep; (270):4-7. PubMed ID: 1884556
[No Abstract] [Full Text] [Related]
4. Chemotherapy for osteosarcoma without high-dose methotrexate: another piece in the puzzle.
Blay JY
Onkologie; 2007 May; 30(5):226-7. PubMed ID: 17460415
[No Abstract] [Full Text] [Related]
5. High-dose methotrexate is effective in osteosarcoma so what is the problem?
Cohen IJ
J Pediatr Hematol Oncol; 2009 Dec; 31(12):892-4. PubMed ID: 19887958
[No Abstract] [Full Text] [Related]
6. [Neoadjuvant therapy for localized osteosarcoma of extremities. Results from the Cooperative osteosarcoma study group COSS of 925 patients].
Bielack S; Kempf-Bielack B; Schwenzer D; Birkfellner T; Delling G; Ewerbeck V; Exner GU; Fuchs N; Göbel U; Graf N; Heise U; Helmke K; von Hochstetter AR; Jürgens H; Maas R; Münchow N; Salzer-Kuntschik M; Treuner J; Veltmann U; Werner M; Winkelmann W; Zoubek A; Kotz R
Klin Padiatr; 1999; 211(4):260-70. PubMed ID: 10472560
[TBL] [Abstract][Full Text] [Related]
7. [Neoadjuvant treatment in osteosarcomas].
Kalifa C; Brugières L; Le Deley MC
Bull Cancer; 2006 Nov; 93(11):1115-20. PubMed ID: 17145581
[TBL] [Abstract][Full Text] [Related]
8. [Adjuvant chemotherapy of osteosarcoma].
Yamawaki S; Isu K; Ubayama Y; Takeda N; Yagi T; Usui M; Isii S
Gan To Kagaku Ryoho; 1990 Feb; 17(2):180-8. PubMed ID: 2301948
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy in osteosarcoma. The Scandinavian Sarcoma Group experience.
Saeter G; Wiebe T; Wiklund T; Monge O; Wahlqvist Y; Engström K; Forestier E; Holmström T; Stenwig AE; Willén H; Brosjö O; Follerås G; Alvegård TA; Strander H
Acta Orthop Scand Suppl; 1999 Jun; 285():74-82. PubMed ID: 10429627
[No Abstract] [Full Text] [Related]
10. Influence of methotrexate dose intensity on outcome of patients with high grade osteogenic osteosarcoma: analysis of the literature.
Bielack SS; Beron G; Winkler K
Cancer; 1997 Aug; 80(3):516-8. PubMed ID: 9241087
[No Abstract] [Full Text] [Related]
11. High-dose methotrexate in osteosarcoma: let the questions surcease--time for final acceptance.
Jaffe N; Gorlick R
J Clin Oncol; 2008 Sep; 26(27):4365-6. PubMed ID: 18802144
[No Abstract] [Full Text] [Related]
12. [Neoadjuvant chemotherapy of osteosarcoma. Preliminary results of the cooperative COSS-86 osteosarcoma study].
Bieling P; Bielack S; Delling G; Jürgens H; Kotz R; Dose C; Astheimer H; Exner G; Gadner H; Graf N
Klin Padiatr; 1991; 203(4):220-30. PubMed ID: 1942929
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant high-dose methotrexate, cisplatin, and doxorubicin for the management of patients with nonmetastatic osteosarcoma.
Weiner MA; Harris MB; Lewis M; Jones R; Sherry H; Feurer EJ; Johnson J; Lahman E
Cancer Treat Rep; 1986 Dec; 70(12):1431-2. PubMed ID: 3466693
[No Abstract] [Full Text] [Related]
14. The importance of doxorubicin and methotrexate dose intensity in the chemotherapy of osteosarcoma.
Kawai A; Sugihara S; Kunisada T; Hamada M; Inoue H
Arch Orthop Trauma Surg; 1996; 115(2):68-70. PubMed ID: 9063854
[TBL] [Abstract][Full Text] [Related]
15. Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651.
Goorin AM; Schwartzentruber DJ; Devidas M; Gebhardt MC; Ayala AG; Harris MB; Helman LJ; Grier HE; Link MP;
J Clin Oncol; 2003 Apr; 21(8):1574-80. PubMed ID: 12697883
[TBL] [Abstract][Full Text] [Related]
16. Interdisciplinary combined treatment of craniofacial osteosarcoma with neoadjuvant and adjuvant chemotherapy and excision of the tumour: a retrospective study.
Thiele OC; Freier K; Bacon C; Egerer G; Hofele CM
Br J Oral Maxillofac Surg; 2008 Oct; 46(7):533-6. PubMed ID: 18436357
[TBL] [Abstract][Full Text] [Related]
17. Influence of methotrexate dose intensity on outcome of patients with high grade osteogenic osteosarcoma. Analysis of the literature.
Delepine N; Delepine G; Bacci G; Rosen G; Desbois JC
Cancer; 1996 Nov; 78(10):2127-35. PubMed ID: 8918406
[TBL] [Abstract][Full Text] [Related]
18. [A case of subacute transient cerebral dysfunction in a osteosarcoma patient following high-dose methotrexate].
Yamada K; Takahashi M; Yoshida M
Gan To Kagaku Ryoho; 2002 Mar; 29(3):469-72. PubMed ID: 11915742
[TBL] [Abstract][Full Text] [Related]
19. Combination of 18F-FDG PET/CT and diffusion-weighted MR imaging as a predictor of histologic response to neoadjuvant chemotherapy: preliminary results in osteosarcoma.
Byun BH; Kong CB; Lim I; Choi CW; Song WS; Cho WH; Jeon DG; Koh JS; Lee SY; Lim SM
J Nucl Med; 2013 Jul; 54(7):1053-9. PubMed ID: 23670899
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant chemotherapy for osteosarcoma of the extremities: the Rizzoli Institute experience.
Bacci G; Avella M; Picci P; Ruggieri P; Biagini R; Ferruzzi A; Casadei R; Caldora P; Campanacci M
Chir Organi Mov; 1990; 75(1 Suppl):57-9. PubMed ID: 2249559
[No Abstract] [Full Text] [Related]
[Next] [New Search]
